Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis

• Main Authors: M. M. Kostik (Author), M. F. Dubko (Author), L. S. Snegireva (Author), V. V. Masalova (Author), T. L. Kornishina (Author), T. S. Likhacheva (Author), I. A. Chikova (Author), E. A. Isupova (Author), E. M. Kuchinskaya (Author), N. I. Glebova (Author), O. V. Kalashnikova (Author), V. G. Chasnykh (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2013-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: to perform retrospective evaluation of tocilizumab (TCZ) treatment every 2 and 4 weeks. Patients and methods: 33 children with systemic juvenile idiopathic arthritis (sJIA) were observed. Results: children, who need TCZ treatment every 2 weeks had more severe sJIA course. Patients which were tr...